Parkinson's disease treatment may cause impulse–control disorder via dopamine D3 receptors
Chronic restraint stress increases the protein expression of VEGF and its receptor VEGFR-2 in the prefrontal cortex
Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum
Pharmacological MRI response to a selective dopamine transporter inhibitor, GBR12909, in awake and anesthetized rats
The sigma agonist 1,3-Di- o -tolyl-guanidine reduces the morphological and behavioral changes induced by neonatal ventral hippocampus lesion in rats
Similar serotonin-2A receptor binding in rats with different coping styles or levels of aggression